Sort   by:  
 Page size 
CEACAM5-specific CAR NK-92 cells were engineered to target CEACAM5-expressing lung tumor cells. To study their transcriptional response during tumor engagement, parental NK-92 cells, CEACAM5-CAR NK-92 cells, hydrocortisone-treated CAR NK-92 cells, NR3C1-knockout (cortisol-resistant) CAR NK-92 cells,...
ORGANISM(S): Homo sapiens 
Identification of the mechanisms through which BET inhibitor (OTX-015) stimulates natural killer (NK) activation. RNA-seq was performed comparing vehicle- (DMSO) to OTX-015-treated NK-92 cell line.
ORGANISM(S): Homo sapiens 
Transcriptomic profiling of NK-92, CAR NK-92, and NR3C1-knockout CAR NK-92 cells following co-culture with CEACAM5⁺ A549 lung cancer cells
RNA-seq for NK-92, and NK-IL-7R-IM cells
Functional assessment for clinical use of serum-free adapted NK-92 cells
NK-92 and NK-92 DNAM-1
Transcriptional profiling of IL-2 activated NK-92 cells compared to no cytokines activated NK-92 cells overexpressing IL-7R insertional mutation (NK-IL-7R-IM)
ORGANISM(S): Homo sapiens 
2026-04-22 | GSE246165 | GEO
RNA-seq of NK-92 cell line upon BET inhibitor treatment (OTX-015)
RNA-seq analysis of NK-92 cells expressing Vaccinia virus (VACV) poxin (encoded by the B2R gene)
Effect of overexpressing a constitutively active human NHE1 (SLC9A1) on gene expression of NK-92 natural killer cell line
Sort   by:  
 Page size